Showing results (11-20 of 142) with videos related to
Sort By:
Pageof 15
Clinical Chemistry and Laboratory Medicine|October 4, 2005
Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortalityRainer H Böger, Renke Maas, Friedrich Schulze, et al.Scientific Reports|July 8, 2017
The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2BAnja Chafai, Martin F Fromm, Jörg König, et al.Plos One|November 5, 2016
Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective StudiesSabrina Schlesinger, Svenja R Sonntag, Wolfgang Lieb, et al.Clinical Pharmacokinetics|May 13, 2003
Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stressEdzard Schwedhelm, Renke Maas, Raphael Troost, et al.Pharmacological Research|July 15, 2009
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality--an update on patient populations with a wide range of cardiovascular riskRainer H Böger, Renke Maas, Friedrich Schulze, et al.Vascular Medicine (London, England)|January 30, 2003
The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular functionRenke Maas, Edzard Schwedhelm, Jennifer Albsmeier, et al.Plos One|March 14, 2019
The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginineEmir Taghikhani, Renke Maas, Martin F Fromm, et al.Journal of Clinical Medicine|December 11, 2020
Transport of L-Arginine Related Cardiovascular Risk MarkersSofna Banjarnahor, Roman N Rodionov, Jörg König, et al.Journal of Clinical Medicine|July 27, 2022
Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative AnalysisMelanie I Then, Wahram Andrikyan, Martin F Fromm, et al.British Journal of Clinical Pharmacology|June 22, 2021
The CredibleMeds® list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing informationMelanie I Then, Wahram Andrikyan, Renke Maas, et al.Pageof 15